Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/1996
11/28/1996CA2220950A1 Delivery vehicles comprising stable lipid/nucleic acid complexes
11/28/1996CA2218759A1 Novel variants of apolipoprotein a-i
11/27/1996EP0743984A1 Nucleic acid-containing composition, its preparation and use
11/27/1996EP0743982A1 Immortalized human fetal osteoblastic cells
11/27/1996EP0743958A1 Non-viral vector
11/27/1996EP0743949A1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
11/27/1996EP0743948A1 Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions
11/27/1996EP0743859A1 Chimeric oligonucleoside compounds
11/27/1996EP0743820A1 Myoblast therapy for mammalian diseases
11/27/1996CN1136826A Recombinant P53 adenovirus method and compositions
11/26/1996US5578718 Thiol-derivatized nucleosides
11/26/1996US5578483 Receptor transcription-repression activity compositions and methods
11/26/1996US5578287 Three-step pretargeting methods using improved biotin-active agent
11/21/1996WO1996036730A1 Cell death protein
11/21/1996WO1996036714A1 Nucleic acid molecule for treating b cell malignant tumor, process for producing the same and utilization of the same
11/21/1996WO1996036709A1 Transforming growth factor alpha hii
11/21/1996WO1996036706A1 A method for large scale plasmid purification
11/21/1996WO1996036698A1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME
11/21/1996WO1996036641A1 Susceptibility gene for obesity and type ii diabetes mellitus
11/21/1996WO1996036366A1 Gene therapy for effector cell regulation
11/21/1996WO1996036365A1 Gene therapy of hepatocellular carcinoma through cancer-specific gene expression
11/21/1996WO1996036364A1 Recombinant viral vector system
11/21/1996WO1996036363A1 Method for pharmaceutical delivery
11/21/1996WO1996036362A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996WO1996036354A2 Anticancer vaccine comprising il6/il6 receptor transfected cells
11/21/1996WO1996036317A1 Production scale method of forming microparticles
11/21/1996WO1996036314A2 Method for drug delivery to the pulmonary system
11/21/1996WO1996036227A1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
11/21/1996WO1996029407A3 Cellubrevin homologs
11/21/1996CA2221305A1 Gene therapy for effector cell regulation
11/21/1996CA2221292A1 Recombinant viral vector system
11/21/1996CA2221269A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996CA2220867A1 A method for large scale plasmid purification
11/21/1996CA2219984A1 Cell death protein
11/21/1996CA2194692A1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
11/20/1996EP0742834A1 Method of preparing a viral vector by homologous intermolecular recombination
11/20/1996EP0742794A1 Interleukin-6 (il-6) antagonists
11/20/1996EP0742790A1 Substituted purines and oligonucleotide cross-linking
11/20/1996CN1136327A Using antisense oligonucleotides to modulate nerve growth and to reverse 'beta'/A4 amyloid-induced morphology
11/20/1996CN1136281A Arteriosclerosis remedy
11/19/1996US5576206 Human papilloma virus genes and their use in gene therapy
11/14/1996WO1996035798A1 Improved retroviral vectors, especially suitable for gene therapy
11/14/1996WO1996035797A1 Hbv vectors and cells for producing the same
11/14/1996WO1996035793A1 Animal gene therapy
11/14/1996WO1996035787A1 Nucleic acids for treating obesity
11/14/1996WO1996035782A1 Il-6 activity inhibitor
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035716A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035703A1 Human inhibitor of apoptosis gene 1
11/14/1996WO1996035455A1 Gene therapy through transduction of oral epithelial cells
11/14/1996WO1996035454A1 Stable virus packaging cell lines
11/14/1996WO1996035430A1 REMEDY AND PREVENTIVE FOR DISEASES CAUSED BY NF-λB
11/14/1996WO1996032087A3 Transgenic fish in the treatment of diabetes
11/14/1996WO1996027008A3 Agent for treating tumours and other hyperplasia
11/14/1996WO1996025501A3 Method and composition for regulating apoptosis
11/14/1996WO1996024378A3 Delivery of exogenous compounds
11/14/1996WO1996011712A3 Cell-specific gene delivery vehicles
11/14/1996DE19517532A1 HBV-Vektoren und Zellen zu ihrer Bereitstellung HBV vectors and cells to their provision
11/14/1996CA2220917A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996CA2220910A1 Hbv vectors and cells for producing the same
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2220670A1 Human inhibitor of apoptosis gene 1
11/14/1996CA2220472A1 Genetically treated animals
11/14/1996CA2218808A1 Improved retroviral vectors, especially suitable for gene therapy
11/14/1996CA2218529A1 Nucleic acids for treating obesity
11/13/1996EP0741785A1 Methods and compositions for stimulating bone cells
11/13/1996EP0741783A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins
11/13/1996EP0741781A1 Embryonic stem cell isolation
11/13/1996EP0741578A1 Human growth hormone
11/13/1996CN1135531A Autonomic-replication-type carrier in human's liver-cancer cell specific expression and usage thereof
11/12/1996US5573940 Cells expressing high levels of CD59
11/12/1996US5573925 P53 proteins with altered tetramerization domains
11/12/1996US5573924 Novel receptor cytokine, protein
11/07/1996WO1996034970A1 Improved methods for transfecting t cells
11/07/1996WO1996034969A2 Gene therapy using replication competent targeted adenoviral vectors
11/07/1996WO1996034957A1 Pancreas-derived serpin
11/07/1996WO1996034956A1 Methods for modulating t cell survival by modulating bcl-xl protein level
11/07/1996WO1996034955A1 Method of treating cartilaginous diseases with genetically modified chondrocytes
11/07/1996WO1996034952A1 Expression of tap and lmp in tumour cells
11/07/1996WO1996034943A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034882A1 Single chain insulin with high bioactivity
11/07/1996WO1996034631A1 Method for introducing and expressing genes in animal cells
11/07/1996WO1996029409A3 Rage tumor rejection antigens
11/07/1996WO1996027664A3 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
11/07/1996WO1996015241A3 A polynucleotide tuberculosis vaccine
11/07/1996CA2223272A1 Single chain insulin with high bioactivity
11/07/1996CA2220156A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2219994A1 Method for introducing and expressing genes in animal cells
11/07/1996CA2218390A1 Gene therapy using replication competent targeted adenoviral vectors
11/07/1996CA2218034A1 Pancreas-derived serpin
11/06/1996EP0741188A2 Single chain insulin with high bioactivity
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0590034B1 Method for determining the presence of diabetes associated antibodies or islet cell directed antibodies
11/06/1996CN1134982A Gene of Chinese strain herpes simplex virus thymidine kinase, and application of same
11/05/1996US5571686 Method of using megapoietin for prolonging the survival & viability of platlets
10/1996
10/31/1996WO1996034117A1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1
10/31/1996WO1996034109A1 Single-vial formulations of dna/lipid complexes
1 ... 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 ... 870